Intest Res Search

CLOSE


topic

  • HOME
  • TOPICS
  • Topics
Inflammatory Bowel Diseases
Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
Ritika Rampal, Saurabh Kedia, Mohamad Nahidul Wari, Deepak Madhu, Amit Kumar Singh, Veena Tiwari, V. Pratap Mouli, Srikant Mohta, Govind Makharia, Vineet Ahuja
Intest Res. 2021;19(2):232-238.   Published online May 8, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Effect of acid-reducing agents on clinical relapse in ulcerative colitis with pH-dependent-released 5-aminosalicylic acid: a multicenter retrospective study in Japan
Yosuke Shimodaira, Kengo Onochi, Kenta Watanabe, So Takahashi, Sho Fukuda, Noboru Watanabe, Shigeto Koizumi, Tamotsu Matsuhashi, Katsunori Iijima
Intest Res. 2021;19(2):225-231.   Published online August 18, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Ustekinumab for the treatment of refractory pediatric Crohn’s disease: a single-center experience
Alexandra Cohen, Najma Ahmed, Ana Sant’Anna
Intest Res. 2021;19(2):217-224.   Published online April 22, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry
Ajit Sood, Kirandeep Kaur, Ramit Mahajan, Vandana Midha, Arshdeep Singh, Sarit Sharma, Amarender Singh Puri, Bhabhadev Goswami, Devendra Desai, C. Ganesh Pai, Kiran Peddi, Mathew Philip, Rakesh Kochhar, Sandeep Nijhawan, Shobna Bhatia, N. Sridhara Rao
Intest Res. 2021;19(2):206-216.   Published online July 13, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Graphic abstract
Close layer
prev next
Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF-κB and PPAR-γ pathways
Maged E. Mohamed, Sahar A. Elsayed, Hafez R. Madkor, Heba M. Saad Eldien, Omar M. Mohafez
Intest Res. 2021;19(2):194-205.   Published online August 21, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Temporal trend in the natural history of ulcerative colitis in a country with a low incidence of ulcerative colitis from 2000 through 2018
Satimai Aniwan, Julajak Limsrivilai, Supot Pongprasobchai, Nonthalee Pausawasdi, Piyapan Prueksapanich, Natanong Kongtub, Rungsun Rerknimitr
Intest Res. 2021;19(2):186-193.   Published online August 18, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?
Nor Hamizah Shafiee, Zahara Abdul Manaf, Norfilza M. Mokhtar, Raja Affendi Raja Ali
Intest Res. 2021;19(2):171-185.   Published online February 3, 2021
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
Steven Nicolaides, Abhinav Vasudevan, Tony Long, Daniel van Langenberg
Intest Res. 2021;19(2):158-170.   Published online October 13, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Clinical practice guideline for endoscopic resection of early gastrointestinal cancer
Chan Hyuk Park, Dong-Hoon Yang, Jong Wook Kim, Jie-Hyun Kim, Ji Hyun Kim, Yang Won Min, Si Hyung Lee, Jung Ho Bae, Hyunsoo Chung, Kee Don Choi, Jun Chul Park, Hyuk Lee, Min-Seob Kwak, Bun Kim, Hyun Jung Lee, Hye Seung Lee, Miyoung Choi, Dong-Ah Park, Jong Yeul Lee, Jeong-Sik Byeon, Chan Guk Park, Joo Young Cho, Soo Teik Lee, Hoon Jai Chun
Intest Res. 2021;19(2):127-157.   Published online October 13, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Whipple disease mimicking inflammatory bowel disease
Maiko Tatsuki, Takashi Ishige, Yoshiko Igarashi, Reiko Hatori, Akira Hokama, Junko Hirato, Aleixo Muise, Takumi Takizawa, Hirokazu Arakawa
Intest Res. 2021;19(1):119-125.   Published online July 3, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
Hiromichi Shimizu, Toshimitsu Fujii, Shuji Hibiya, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe
Intest Res. 2021;19(1):115-118.   Published online June 11, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Miscellaneous
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Ashish Agarwal, Alka Singh, Wajiha Mehtab, Vipin Gupta, Ashish Chauhan, Mahendra Singh Rajput, Namrata Singh, Vineet Ahuja, Govind K. Makharia
Intest Res. 2021;19(1):106-114.   Published online April 22, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    
Close layer
prev next
Inflammatory Bowel Diseases
Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, Toshifumi Hibi
Intest Res. 2021;19(1):95-105.   Published online July 10, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, Deng-Chyang Wu, Suk-Kyun Yang, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res. 2021;19(1):83-94.   Published online December 31, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res. 2021;19(1):71-82.   Published online September 4, 2020
Full text    PubReader    ePub    Crossref - TDM    PDF    Supplementary Material
Close layer
prev next
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 305, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2021 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next